摘要
目的探讨复方消化酶在治疗消化不良中的安全性及不良反应。方法将在本院住院的42例消化不良临床患者作为研究对象，患者随机分为对照组和观察组，各21例，其中对照组每次服用3片多酶，每天服用3次．总疗程为3周，观察组服用复方消化酶，（1-2）片／次，每天3次，总疗程为2周。对比两组在治疗前后的症状缓解情况及安全性。结果观察组在治疗前后的症状缓解程度明显优于对照组，两组的治疗效果差异有统计学意义（P〈0．05）；两组在治疗前后都未出现明显的不良反应。结论复方消化酶针对消化不良具有良好的治疗效果，且治疗的安全性较高，具有重要的临床推广价值。
Objective To study the safety of compound digestive enzymes in the treatment of indigestion and adverse reaction. Methods In our hospital 42 dyspepsia clinical patients with implementation were randomly divided into two groups, the Observation group and the control group, each of 21 cases, the control group each taking 3 multi enzyme daily three times, the total course of treatment for three weeks, the observation group were treated with compound digestive enzyme, 1 or 2 tablets/time, three times a day, total course of treatment for two weeks. The observation group and the control group relief and safety in the treatment of symptoms were compared. Results In the observation group, symptoms before and after treatment in remission was significantly better than the control group and the therapeutic effect of the two groups exist difference with statistical significance（P〈0.05）; two groups before and after treatment had no obvious adverse reactions. Conclusion The compound digestive enzyme has good therapeutic effect in the treatment of dyspepsia, with higher safety, and has important clinical value.
出处
《中国现代医生》
2016年第11期63-65,共3页
China Modern Doctor
关键词
复方消化酶
消化不良
安全性
不良反应
Compound digestive enzyme
Dyspepsia
Safety
Adverse reaction
